Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Jinong Li"'
Autor:
Issam Makhoul, Richard D. Beger, Li Rong Yu, Jinong Li, Julia T. Lathrop, Valentina K. Todorova, Zhijun Cao, Jane P.F. Bai, Jeanne Y. Wei, Suzanne Klimberg, Jaclyn R. Daniels
Publikováno v:
Experimental Biology and Medicine. 243:248-255
Cancer treatment with doxorubicin (DOX) can induce cumulative dose-dependent cardiotoxicity. Currently, there are no specific biomarkers that can identify patients at risk during the initial doses of chemotherapy. The aim of this study was to examine
Publikováno v:
Sleep. 43:A392-A392
Introduction Sleep disturbance is reported in up to 60% of cancer patient. In traditional Chinese medicine, evidence suggests that auricular point acupressure (APA) improves sleep. However, little is known about APA’s effect on sleep disturbance in
Autor:
Theodore N. Tsangaris, Daniel W. Chan, Junma Zhou, Deanna Shapiro, Michelle Brotzman, Neil B. Friedman, Jinong Li, Yee Chan-Li, Bruce J. Trock
Publikováno v:
Breast Cancer Research and Treatment. 123:73-86
By comparison of mass spectra from a small cohort of nipple aspiration fluids (NAF), we previously discovered a panel of five candidate breast cancer biomarkers among them an unidentified 4.7 kD peptide BF5. The purposes of the present study were to
Autor:
Xiaodong Yu, Seema A. Khan, Savitri Krishnamurthy, Jing Zhao, Daniel W. Chan, Saraswati Sukumar, Eric Schilling, Jinong Li, Henry Mark Kuerer, Julie R. Lange
Publikováno v:
Clinical Cancer Research. 11:8312-8320
Purpose: To establish a comprehensive proteomic approach for biomarker discovery and validation in breast fluid. Experimental Design: A total of 95 specimens from three institutions were used including 10 nipple aspiration fluid (5 stage I/II cancero
Autor:
C. Nicole White, Xiao Ying Meng, Yinhua Yu, Ettore Seregni, Nancy E. Davidson, Rosaria Orlandi, Jing Zhao, Daniele Morelli, Zhen Zhang, Jason M. Rosenzweig, Daniel W. Chan, Eric T. Fung, Jinong Li
Publikováno v:
Clinical Chemistry. 51:2229-2235
Background: We previously selected a panel of 3 breast cancer biomarkers (BC1, BC2, and BC3) from serum samples collected at a single hospital based on their collective contribution to the optimal separation of breast cancer patients and noncancer co
Autor:
Neville F. Hacker, Andrew Berchuck, Daniel W. Chan, Zhen Zhang, Henk W.A. de Bruijn, Robert C. Bast, Ian Jacobs, Lori J. Sokoll, Ate G.J. van der Zee, Yinhua Yu, Carolien van Haaften-Day, Jason M. Rosenzweig, Alex J. Rai, Jinong Li, Bonnie Cameron, Young Y. Wang, Xiao Ying Meng, Eric T. Fung
Publikováno v:
Cancer Research, 64(16), 5882-5890. AMER ASSOC CANCER RESEARCH
Early detection remains the most promising approach to improve long-term survival of patients with ovarian cancer. In a five-center case-control study, serum proteomic expressions were analyzed on 153 patients with invasive epithelial ovarian cancer,
Publikováno v:
Clinical Chemistry. 48:1296-1304
Background: Surface-enhanced laser desorption/ionization (SELDI) is an affinity-based mass spectrometric method in which proteins of interest are selectively adsorbed to a chemically modified surface on a biochip, whereas impurities are removed by wa
Publikováno v:
Journal of proteomics. 74(12)
Issues associated with the translation of complex proteomic biomarkers from discovery to clinical diagnostics have been widely discussed among academic researchers, government agencies, as well as assay and instrumentation manufacturers. Here, we pro
Publikováno v:
Clinical chemistry. 56(8)
BACKGROUND We evaluated the analytical performance of 4 cystatin C assays (Siemens N Latex on BNII, Roche Tina-quant on Cobas c501, Genzyme on Cobas c501, and Tosoh ST AIA-PACK on Tosoh AIA-600II) according to guidelines published by the Clinical and
Autor:
Young Y, Wang, Francis P, Kuhajda, Jinong, Li, Teia T, Finch, Paul, Cheng, Clare, Koh, Tianwei, Li, Lori J, Sokoll, Daniel W, Chan
Publikováno v:
Journal of experimental therapeuticsoncology. 4(2)
Overexpression of fatty acid synthase (FAS EC 2.3.1.85) is associated with certain cancers and therefore is a putative tumor marker. The presence of FAS in patients with breast, prostate, colon, ovarian, and other cancers has been reported. The mecha